Sular (Covis Pharma)
Welcome to the PulseAid listing for the Sular drug offered from Covis Pharma. This Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Calcium Channel Antagonists [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Covis Pharma |
NON-PROPRIETARY NAME: | nisoldipine |
SUBSTANCE NAME: | NISOLDIPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Calcium Channel Antagonists [MoA],Decreased Blood Pressure [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-02-03 |
END MARKETING DATE: | 0000-00-00 |
Sular HUMAN PRESCRIPTION DRUG Details:
Item Description | Sular from Covis Pharma |
LABELER NAME: | Covis Pharma |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.5(mg/1) |
START MARKETING DATE: | 2017-02-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70515-500_c5bb62b8-1488-4330-a4b2-5d8d569f8d6a |
PRODUCT NDC: | 70515-500 |
APPLICATION NUMBER: | NDA020356 |
Other NISOLDIPINE Pharmaceutical Manufacturers / Labelers: